A Brief History of Tofacitinib Forbes In the summer of 1993, Dr. Paul Changelian, a scientist in Pfizer's immune suppression group, was looking for a new way to prevent organ transplant rejection. Paul, always on the lookout for new ideas, particularly ones related to suppressing an ... |
